BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/12/2020 11:28:25 AM | Browse: 747 | Download: 1405
 |
Received |
|
2019-10-28 05:14 |
|
Peer-Review Started |
|
2019-10-23 07:48 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2019-11-18 16:43 |
|
Revised |
|
2019-11-24 02:02 |
|
Second Decision |
|
2019-12-21 04:48 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2019-12-23 19:02 |
|
Articles in Press |
|
2019-12-23 19:02 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2019-12-29 02:49 |
|
Typeset the Manuscript |
|
2020-01-17 01:19 |
|
Publish the Manuscript Online |
|
2020-03-12 11:28 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Basic Study |
| Article Title |
Increased KIF21B expression is a potential prognostic biomarker in hepatocellular carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Hui-Qi Zhao, Bao-Long Dong, Min Zhang, Xiao-Hua Dong, Yu He, Shi-Yong Chen, Biao Wu and Xiao-Jun Yang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the Natural Science Foundation of Gansu Province |
No.17JR5RA034 |
| the National Natural Science Foundation of China |
No.81260326 and No. 81660398 |
|
| Corresponding Author |
Xiao-Jun Yang, MD, PhD, Chief Doctor, Professor, Surgeon, Department of General Surgery, Gansu Provincial Hospital, 204Donggang West Road, Chengguan District, Lanzhou 730000, Gansu Province, China. yangxjmd@aliyun.com |
| Key Words |
Hepatocellular carcinoma; KIF21B; Proliferation; Apoptosis; Prognosis; |
| Core Tip |
The kinesin superfamily protein member KIF21B plays an important role in regulating mitotic progression; however, the function and mechanisms of KIF21B in cancer, particularly in hepatocellular carcinoma, are unknown. We explored the role of KIF21B in hepatocellular carcinoma and elucidated its clinical significance. Our findings suggest that KIF21B may be a potential biomarker for hepatocellular carcinoma. |
| Publish Date |
2020-03-12 11:28 |
| Citation |
Zhao HQ, Dong BL, Zhang M, Dong MH, He Y, Chen SY, Wu B, Yang XJ. Increased KIF21B expression is a potential prognostic biomarker in hepatocellular carcinoma. World J Gastrointest Oncol 2020; 12(3): 276-288 |
| URL |
https://www.wjgnet.com/1948-5204/full/v12/i3/276.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v12.i3.276 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
